Caption Management, LLC Arcutis Biotherapeutics, Inc. Call Options Transaction History

Caption Management, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$8.32 - $11.0 $255,424 - $337,700	30,700 Added 41.32%	105,000 $976,000
Q2 2024 Aug 14, 2024	BUY	$7.24 - $12.53 $537,932 - $930,979	74,300 New	74,300 $690,000
Q2 2023 Aug 14, 2023	BUY	$7.51 - $15.0 $488,150 - $975,000	65,000 Added 92.86%	135,000 $1.29 Million
Q1 2023 May 15, 2023	SELL	$10.23 - $17.14 $2.11 Million - $3.53 Million	-206,000 Reduced 74.64%	70,000 $770,000
Q4 2022 Feb 14, 2023	BUY	$13.96 - $20.4 $2.95 Million - $4.3 Million	211,000 Added 324.62%	276,000 $4.08 Million
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $1.16 Million - $1.75 Million	65,000 New	65,000 $1.24 Million
Q1 2022 May 13, 2022	SELL	$14.38 - $22.79 $266,030 - $421,615	-18,500 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$14.98 - $25.5 $277,130 - $471,750	18,500 New	18,500 $384,000

197

129M

738K

82K

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $763M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.